HomepageMedicinePoseida Therapeutics Enters into Partnership with Astellas Subsidiary Xyphos Medicine Poseida Therapeutics Enters into Partnership with Astellas Subsidiary Xyphos admin Posted on May 6, 2024 The two companies will work together to develop gene therapies in oncology. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostGodrej Properties Q4 net profit up 14% Next PostSustainability Activists Take Aim at Disposable Hotel Slippers You Might Also Like Medicine Zepbound Expected to Surpass Wegovy in Weight Loss Market, New Report States admin January 6, 2025 Medicine Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA admin April 21, 2024 Medicine Overall Impact of AI-Driven Discovery Platforms admin February 6, 2025 Medicine Gilead Discontinuing Development of Magrolimab in Hematologic Cancers Following Full Clinical Hold by FDA for Increased Risk of Death admin February 8, 2024
Medicine Zepbound Expected to Surpass Wegovy in Weight Loss Market, New Report States admin January 6, 2025
Medicine Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA admin April 21, 2024
Medicine Gilead Discontinuing Development of Magrolimab in Hematologic Cancers Following Full Clinical Hold by FDA for Increased Risk of Death admin February 8, 2024